VYOME HOLDINGS, INC. Increase (Decrease) in Other Operating Liabilities
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Other Operating Liabilities of -$451.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2020-02-27
- VYOME HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2019 was -$451.00K, a 763.24% decline from fiscal 2018.
- VYOME HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2018 was $68.00K, a 89.74% decline from fiscal 2017.
- VYOME HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2017 was $663.00K.
- VYOME HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2016 was -$416.00K, a 141.23% decline from fiscal 2015.
| Period end | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|
| 2019-12-31 | -$451.00K 10-K · filed 2020-02-27 |
| 2018-12-31 | $68.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $663.00K 10-K · filed 2019-02-22 |
| 2016-12-31 | -$416.00K 10-K · filed 2018-03-05 |
| 2015-12-31 | $1.01M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |